Topics

Companies Related to "Ultrasensitive Electroanatomic Mapping to Adjudicate Endpoints for Ablation In Paroxysmal AF Patients Using Cryoballoon" [Most Relevant Company Matches] RSS

00:37 EST 21st January 2020 | BioPortfolio

Here are the most relevant search results for "Ultrasensitive Electroanatomic Mapping to Adjudicate Endpoints for Ablation In Paroxysmal AF Patients Using Cryoballoon" found in our extensive corporate database of over 50,000 company records.

Showing "Ultrasensitive Electroanatomic Mapping Adjudicate Endpoints Ablation Paroxysmal Patients" Companies 1–25 of 4,100+

Relevant

Cardima Incorporated

Cardima®, Inc. is developing minimally invasive, single-use, microcatheter-based systems for the mapping and ablation of the two most common forms of cardiac arrhythmias: atrial fibrillation ("AF") and ventricular tachycardia ("VT"). Arrhythmias are abnormal electrical heart rhythms that adversely affect the mechanical activities of the heart and can potentially be fatal.The microcatheter syste...


Microsulis Medical Ltd

Microsulis Medical is a specialist medical device company with market leading solutions in microwave ablation. The company’s products deliver significant technological and clinical advances to physicians and patients in minimally invasive, soft tissue ablation.

Imaging Endpoints

Imaging Endpoints (IE) is an imaging research and core laboratory that provides comprehensive imaging CRO (iCRO) services and technology solutions throughout the clinical trial process. IE is one of the largest iCROs globally and is widely recognized for conducting the industry’s most complex imaging trials.


Acessa Health Inc.

The Acessa System is the only radiofrequency ablation system cleared by the U.S. Food and Drug Administration and CE marked for use in percutaneous, laparoscopic coagulation and ablation of soft tissue, including treatment of symptomatic uterine fibroids under laparoscopic ultrasound guidance. It has been the subject of 20 peer-reviewed publications across...

Biosense Webster, Inc.

Biosense Webster, Inc., a Johnson & Johnson company, pioneered electrophysiology diagnostic catheters more than 30 years ago and continues to lead the industry as an innovative provider of advanced diagnostic, therapeutic and mapping tools. As the leader in navigation systems and ablation therapy, Biosense Webster, Inc.'s technology includes the largest in...

Endosense

Founded in Geneva in 2003, Endosense is a medical technology company focused on improving efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias. The company has pioneered the use of contact force measurement in catheter ablation, with the development of its proprietary Touch+® sensor technology. Endosenseâ€...

NeuWave Medical Inc.

NeuWave Medical is a privately held medical device company based in Madison, Wisconsin with a satellite office in Minneapolis, Minnesota. The science and technology behind the NeuWave Intelligent Ablation System is derived from several practicing physicians and PhD’s specializing in ablation from the University of Wisconsin who were looking for a bett...

LuxCath, LLC

LuxCath is a medical technology company founded to address persistent unmet needs in the catheter ablation treatment of cardiac arrhythmias. The company has developed breakthrough technology that uses fluorescence and optics to directly view lesions during cardiac ablation procedures. Its flagship product, the OmniView™ light-guided ablation catheter, ...

LuxCath LLC

LuxCath is a leader in catheter-based, real-time, optical tissue-electrode contact assessment, lesion progression monitoring, and lesion visualization for cardiac ablation. LuxCath’s technology is applicable to all cardiac ablation and is focused on Atrial Fibrillation ablation as its initial target market. The company’s technology involves conti...

Cardima, Inc.

Cardima, Inc. has developed the PATHFINDER® Series of diagnostic catheters, and the NAVIPORT® deflectable guiding catheter, the INTELLITEMP® Energy Management Device and the Surgical Ablation System. All of these Cardima devices have received CE mark approval and U.S. Food and Drug Administration (FDA) 510(k) clearance. The REVELATION® Series o...

CSA Medical, Inc.

CSA Medical has advanced the proven science of cryotherapy. With the CryoSpray Ablation System, physicians have the ability to quickly and easily freeze, destroy and remove unwanted tissue, freeing patients from the discomfort and worry. The CryoSpray Ablation system uses a patented technology to deliver liquid nitrogen through a catheter in a standard endoscope. This system of repetitive freeze-t...

AEGEA Medical, Inc.

AEGEA Medical is pioneering the application of its Adaptive Vapor Ablation technology to deliver therapies that provide high quality patient outcomes to a wider range of patients. AEGEA’s FDA approved water vapor technology enables the delivery of a safe and effective endometrial ablation for the treatment of menorrhagia in a simple, office-based proc...

TROD Medical NV/SA

Trod Medical is a Medical Device Company, with headquarters in Leuven (Belgium) and Tampa Bay area (USA). The Company, incepted in 2006 by Dr. Andre Faure, developed significant expertise in developing innovative ablation technologies, particularly Radio Frequency (RF) ablation devices.

Thermedical

Based in Somerville, Mass., Thermedical is a privately held company founded by Michael G. Curley, Ph.D., and Patrick S. Hamilton, Ph.D. Under multiple National Institutes of Health (NIH) Small Business Innovation Research (SBIR) Grants and a Massachusetts Life Sciences Center Small Business Matching Grant (SBMG) Award, Thermedical is developing ther...

Alexion Pharmaceuticals Incorporated

Alexion is a global biopharmaceutical company that combines groundbreaking science with a steadfast commitment to meeting the needs of patients living with severe, life-threatening and often ultra-rare diseases. Alexion scientists are among the first in the world to unlock the therapeutic potential of inhibiting terminal complement, a group of proteins that play an important role in the body's imm...

Endocare, Inc.

Endocare, Inc.--www.endocare.com-- is an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation. Endocare has initially concentrated on developing technologies for the treatment of prostate cancer and believes that its proprietary technologies have broad applications across a number of markets, including the ablation of tumors...

BARRX Medical Inc.

BARRX Medical, Inc. develops endoscopic treatment solutions for Barrett's esophagus and other chronic gastroenterological diseases. Barrett's is a precancerous condition of the lining of the esophagus (swallowing tube) caused by gastroesophageal reflux disease, or GERD. The company's HALO360( )and HALO90 ablation systems provide a uniform and controlled ablation effect, which removes diseased ti...

Promisec, Inc.

Promisec (www.promisec.com) transforms how global companies manage and control their endpoints. Through actionable endpoint intelligence, Promisec makes managing complex IT operations simpler and more efficient for millions of endpoints. Promisec’s patented agentless technology provides full visibility of enterprise environments, often detecting previ...

BARRX Medical, Inc.

BARRX Medical, Inc. develops endoscopic treatment solutions for Barrett's esophagus and other chronic gastroenterological diseases. Barrett's is a precancerous condition of the lining of the esophagus (swallowing tube) caused by gastroesophageal reflux disease, or GERD. The company's HALO FLEX, HALO 360( )and HALO 90 ablation systems are designed to provide a uniform and controlled ablation effe...

Integral Molecular Inc.

Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies against under-exploited membrane protein targets, including GPCRs, ion channels, transporters, immuno-oncology targets, and viral envelope proteins. Integral Molecular has a long-standing interest in the structure and func...

Ablation Frontiers, Inc.

Alexion Pharmaceuticals Inc.

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion developed and commercializes Soliris® (eculizumab), the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemo...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic devices. The company was initially formed following research collaboration between Chemring and the University of Bath in 1993. The company leads the field in microwave technology ...

Avenda Health

Avenda Health is the only image-guided ablation system (pending FDA clearance) that leverages artificial intelligence to treat only the tumor, minimizing the side effects of the treatment on the patient. Unlike other options, this approach has the potential to offer patients a personalized treatment performed in-office using local anesthesia, potentially a...

AllerGenis, LLC

Established in 2017 and located in Hatfield, PA, AllerGenis develops precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose, assess and monitor patients with food allergies. The company was founded out of a collaboration between Genisphere, provider of the 3DNA® platform for targeted drug delivery, and Hugh S...


More From BioPortfolio on "Ultrasensitive Electroanatomic Mapping to Adjudicate Endpoints for Ablation In Paroxysmal AF Patients Using Cryoballoon"

Quick Search

Corporate Database Quicklinks